A safer vaccination for Alzheimer's disease?
Tuesday, October 11, 2011 - 11:03
in Health & Medicine
The research shows that in addition to the major histocompatibility complex (MHC) molecules, which present the antigen vaccine to the immune cells, genetic factors, that control some immune cells, influence the quality of response to vaccinations. The results could make it possible to prevent neuroinflammatory reactions, which are major obstacles preventing the use of the vaccination in humans. This study has just been published in the Journal of Immunology.